Russell J. Cox has been Named an Executive of the Year in Biomedical Science

    NEW YORK, NY, August 21, 2015 /24-7PressRelease/ -- Russell J. Cox, Chief Operating Officer of Jazz Pharmaceuticals plc, has been named a Worldwide Branding Executive Professional of the Year in Biomedical Science. While inclusion in Worldwide Branding is an honor, only small selections of members in each discipline are chosen for this distinction. These special honorees are distinguished based on their professional accomplishments, academic achievements, leadership abilities, years of service, and the credentials they have provided in association with their Worldwide Branding membership.

Mr. Cox has 30 years of experience in pharmaceuticals, with one year of experience as chief operating officer of Jazz Pharmaceuticals plc, a biopharmaceutical company that develops, acquires and commercializes new options for the treatment of narcolepsy and hematology oncology. Jazz Pharmaceuticals plc was recently ranked the number one growth company in the biopharmaceutical sector in the last four years. In 2010, the company became very focused on execution, which eventually led to its tremendous growth. Their narcolepsy drug, Xyrem, is the company's biggest asset and has been in a class of its own for the last 13 years. The company has successfully marketed Xyrem strictly on-label, achieving 50 percent revenue growth, which is a real feat for a medication on the market for so long. Jazz Pharmaceuticals plc is now valued at $13 billion in market capital, compared to its initial market capital of less than $1 billion. Focused on improving patients' lives, Jazz Pharmaceuticals plc considers its success a team sport. Keeping within the team spirit, Mr. Cox brings a lot of energy to his job. He considers his greatest career achievement to be joining Jazz Pharmaceuticals' successful management team.

Prior to joining Jazz Pharamaceuticals plc, Mr. Cox served in a variety of senior management roles. He became involved in this profession after studying biomedical science. He had always wanted to work in pharmaceuticals and started his career with Genentech, Inc. Mr. Cox received a Bachelor of Science in biomedical science from Texas A&M University in 1985. He remains affiliated with Genentech, Inc. and BayBio, and serves on the board of directors of Aeglea Biotherapeutics and Vascular Cures. Mr. Cox attributes his many professional successes to his laser-sharp focus on important issues, and his level of diligence regarding commercial execution strategies. Looking to the future, Mr. Cox intends to continue to maximize the commercial and overall success of Jazz Pharmaceuticals plc.

For more information about Jazz Pharmaceuticals plc, please visit http://www.jazzpharma.com.

About Worldwide Branding
For over 15 years, Worldwide Branding has been the leading, one-stop-shop, personal branding company, both in the United States and abroad. From writing professional biographies and press releases, to creating and driving traffic to personal websites, our team of branding experts tailor each product specifically for our clients' needs. We are dedicated to empowering our 600,000 clients with effective branding tools to help them achieve success. From healthcare to finance to education and law, our constituents represent every major industry and occupation, at all career levels.

An international company, we provide our members with access to members in over 52 countries including, the United States, Canada, Australia, the United Kingdom, France, The Netherlands, Germany, Ireland, Spain, Switzerland, South Africa, Belgium, Mexico, Italy, Brazil, Sweden and The United Arab Emirates, just to name a few.

For more information, please visit http://www.worldwidebranding.com.

# # #